Triple-Negative Breast Cancer: Medical Update
When: Tuesday, April 12, 2011
12:00 p.m. to 1:15 p.m. Eastern Daylight Time (EDT)
Living Beyond Breast Cancer presents this teleconference series in partnership with Triple Negative Breast Cancer Foundation.
During the first of two April teleconferences on triple-negative breast cancer, Lisa A. Carey, MD, provides medical updates and treatment news specific to this diagnosis. Among the things you will learn:
- Which groups are at highest risk for developing triple-negative breast cancer
- The types of treatments available in early-stage and metastatic disease
- The latest research on promising new developments in the pipeline
About Our Speaker
Dr. Carey is an associate professor at the University of North Carolina in the department of medicine, division of hematology and oncology. She is an expert in triple-negative breast cancer and led the first trial looking at a new treatment regimen in this breast cancer subtype. Dr. Carey's research interests also focus on breast cancer, including examining different subtypes of breast cancer, evaluating new chemotherapy medicines in early breast cancer, and studying tumor traits that predict response to therapy.
You may also be interested in the April topic for our online ask-the-expert series, Triple-Negative Breast Cancer: Research and Treatment Options.